Overview

A Safety and Efficacy of CCRT With Paclitaxel as Adjuvant Therapy to Post-Operative Advanced Endometrial Cancer Patients

Status:
Unknown status

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether post-operative concurrent chemoradiation with paclitaxel is effective and safe in the treatment of high risk postoperative endometrial cancer patients.

Phase:

Phase 2

Details

Lead Sponsor:

Korean Gynecologic Oncology Group

Treatments:

Albumin-Bound Paclitaxel
Paclitaxel